Goldman Sachs Group Inc Verrica Pharmaceuticals Inc. Transaction History

Goldman Sachs Group Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$4.74 - $6.81 $92,690 - $133,169	19,555 New	19,555 $115,000
Q3 2023 May 14, 2024	BUY	$3.75 - $7.46 $51,963 - $103,373	13,857 New	13,857 $53,000
Q3 2023 Nov 14, 2023	SELL	$3.75 - $7.46 $29,017 - $57,725	-7,738 Reduced 35.83%	13,857 $53,000
Q2 2023 May 14, 2024	SELL	$5.32 - $6.79 $258,392 - $329,790	-48,570 Reduced 69.22%	21,595 $124,000
Q2 2023 Aug 14, 2023	SELL	$5.32 - $6.79 $258,392 - $329,790	-48,570 Reduced 69.22%	21,595 $124,000
Q1 2023 May 14, 2024	BUY	$2.88 - $8.51 $151,404 - $447,379	52,571 Added 298.8%	70,165 $456,000
Q1 2023 May 11, 2023	BUY	$2.88 - $8.51 $202,075 - $597,104	70,165 New	70,165 $456,000
Q3 2022 May 14, 2024	SELL	$2.17 - $4.3 $30,718 - $60,870	-14,156 Reduced 44.59%	17,594 $51,000
Q3 2022 Nov 10, 2022	SELL	$2.17 - $4.3 $30,718 - $60,870	-14,156 Reduced 44.59%	17,594 $0
Q2 2022 May 14, 2024	BUY	$1.81 - $8.93 $57,467 - $283,527	31,750 New	31,750 $61,000
Q2 2022 Aug 15, 2022	BUY	$1.81 - $8.93 $37,915 - $187,065	20,948 Added 193.93%	31,750 $61,000
Q1 2022 May 16, 2022	BUY	$7.59 - $9.49 $81,987 - $102,510	10,802 New	10,802 $88,000

17.4M

6.1K

6.3K

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.